Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2025-12-25 @ 10:15 PM
NCT ID: NCT04697758
Description: None
Frequency Threshold: 0
Time Frame: 48 weeks
Study: NCT04697758
Study Brief: Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Low Dose AXT107 0.1 mg/eye AXT107 0.1 mg: Single intravitreal injection of AXT107 0.1 mg/eye 0 None 3 3 2 3 View
Mid Dose AXT107 0.25 mg/eye AXT107 0.25 mg: Single intravitreal injection of AXT107 0.25 mg/eye 0 None 1 3 1 3 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Ocular Hypertension NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (10.0) View
Glaucoma NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (10.0) View
Gastroenteritis NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (10.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Vitreous Floaters NON_SYSTEMATIC_ASSESSMENT Eye disorders MedDRA (10.0) View